Cellular Senescence Explained

What cellular senescence is

Cellular senescence is a state in which a cell permanently stops dividing but stays alive. It was first described in laboratory dishes in 1961 and happens in response to stresses such as telomere damage, cancer-gene activation and persistent DNA damage. [1] Many senescent cells also release a mix of inflammatory signals known as the senescence-associated secretory phenotype, or SASP. [2] "Zombie cells" is a popular nickname, not a scientific term. This page is education only. It gives no amounts and no advice to take any drug or supplement, and aging is not an approved medical indication for any treatment discussed.

Not simply bad

Senescent cells appear throughout life and play beneficial roles in embryo development, wound healing, immunity and tumor suppression. Their steady build-up with age may also have harmful effects, because they occupy tissue space and release inflammatory signals. [3] A review of treatments aimed at senescent cells notes that senescence helps in wound healing, immunity and tumor suppression, and that the short- and long-term side effects of such treatments are largely unknown. [4] The SASP itself has both helpful and harmful effects depending on the setting. [2] This is one reason "remove them all" is not a simple goal. Label: established as basic biology.

What mouse studies showed

In a 2011 study, mice bred to age quickly were given a genetic tool that lets researchers destroy cells carrying the senescence marker p16. Removing those cells throughout life delayed the onset of several age-related problems in fat tissue, muscle and the eye, and removing them late in life slowed the progress of problems already present. [5] These were specially engineered mice and the cells were removed with a genetic switch, not a drug you could buy. Label: preclinical (cells or animals only). It does not show that people would live longer or healthier lives. See aging in mice, worms and humans and claim check: mouse results prove it works.

What human trials show

Senolytics are treatments meant to remove senescent cells. The combination most often tested in people is the drug dasatinib plus quercetin. [6] The studies below are small, mostly short, and several were run by teams that disclose patents or financial interests in senolytic drugs. [7][8]

A 2026 systematic review found only six completed clinical studies, said safety signals were mostly mild but could not rule out uncommon or long-term harms, and concluded that senolytic approaches are investigational rather than established. [6] Note that the table's conditions are specific diseases, not aging, and none measured lifespan.

Supplements marketed as senolytic

Fisetin is a plant flavonoid with senolytic effects in cells and animals. A 2026 trial protocol states that evidence from randomized human trials is limited. [12] A protocol describes a planned study, not a result. Proper evidence not found for supplement-only senolytic products showing health benefits: we checked PubMed for human fisetin trials and found reviews and study protocols but no completed outcome trial. Label: insufficient evidence; claims on product labels are marketing claims. See quercetin, fisetin and senolytic supplements.

Why measuring senescence is hard

Common markers, such as p16 and a staining test called senescence-associated beta-galactosidase, vary across tissues and settings, which complicates comparing studies and using them in clinics. [13] A drop in a senescence marker is therefore a biomarker change, not a proven health outcome.